DRUG DISCOVERY TODAY
DRUG DISCOVERY TODAY(英文缩写 DRUG DISCOV TODAY),ISSN 1359-6446,eISSN 1878-5832 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
指标来源：jcr_cas_ifqb
期刊简介
暂无简介。
历年影响因子趋势
| 年份 | 影响因子 | JCR 分区 |
|---|---|---|
| - | Q1 | |
| - | Q1 | |
| - | Q1 | |
| - | Q1 | |
| - | Q1 |
DRUG DISCOVERY TODAY 最新收录文献
-
Proteomics studies reveal important information on small molecule therapeutics: a case study on plasma proteins.
The most abundant proteins in serum, such as albumin and IgG, act as molecular sponges that bind and transport low molecular weight proteins/peptides and drugs. In the near future, pharmacoproteomics,…
-
Neuroprotection in traumatic brain injury.
The management of traumatic brain injury (TBI) is challenging and there is a need for neuroprotective therapies. A better understanding of the pathomechanism of TBI, particularly of the evolution of s…
-
The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
One of the most challenging problems, if not the most challenging, in drug development is not to develop drugs to treat diseases of the central nervous system (CNS), but to manage to distribute them t…
-
New anti-tuberculosis drugs in clinical trials with novel mechanisms of action.
Tuberculosis is a major health problem worldwide, with approximately 1.7 million people dying annually from the disease. The long current drug regimen, the emergence of drug resistant strains and HIV …
-
Physiological relevance of GPCR oligomerization and its impact on drug discovery.
The potentially large functional and physiological diversity of G-protein coupled receptor (GPCR) dimers has generated a great deal of excitement about the opportunity that dimerization provides for e…
-
CB(1) receptor antagonism: biological basis for metabolic effects.
The endocannabinoid system (ECS) is a complex physiologic system that affects metabolic pathways. A dysregulated ECS has been demonstrated in animal models of obesity and the expression of the cannabi…
-
Peptide-assisted traffic engineering for nonviral gene therapy.
Many of the challenges facing nonviral gene therapy, to make it as effective as the viral-based version, have yet to be overcome. The technology possesses sufficient biosafety advantages to make the c…
-
Recent developments in microwave-assisted protein chemistries - can this be integrated into the drug discovery and validation process?
Over the past 30 years, biotechnology has evolved as a multibillion dollar industry. A large sector of this industry is associated with translating human genetic information to discover, develop and c…
-
Modern multiple sclerosis treatment - what is approved, what is on the horizon.
In the mid-1990s, the implementation of the immunomodulatory drugs interferon-beta and glatiramer acetate offered the first evidence-based treatment option for multiple sclerosis (MS). These new drugs…
-
The impact of accelerator processors for high-throughput molecular modeling and simulation.
The recent introduction of cost-effective accelerator processors (APs), such as the IBM Cell processor and Nvidia's graphics processing units (GPUs), represents an important technological innovation w…